SecBot SecBot

CMPS

COMPASS Pathways plc
Nasdaq· Pharmaceutical Preparations· Inc. X0· CIK 0001816590 Biotech & Drug Discovery
$8.27 −0.74 (−8.21%)
Nov 16 4:00 PM ET · prev $9.01
Market cap
$1.3B
Small cap
Consensus
Buy
92% Buy or better · 25 analysts
Median target
$21.00
+154% · range $10.00–65.00
1 year
+55.2%
from $5.33 · Nov 17
30 days
−25.6%
from $11.11
52-week range
$4.94–15.19
−46% from high · low Dec 2
Avg volume 20D
3.68M
Nov 2 spike 16.85M
Short interest
17.20M
≈12.1% of shares · −2.6%
Days to cover
7.7
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
1
Q3 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 3 mentions this week
SecBot read BULLISH 2 reports · 90 days
Balance 0 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q3 2026: 22 added (1 new), 17 trimmed or exited.

  • AnalystsBULLISH

    23 of 25 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.395 → −$0.465 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −2.6% to 17.20M shares. 7.7 days to cover, ≈12.1% of shares.

  • TrendDOWNTREND

    30% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
1
new positions
0
exits
FundMoveSharesValue
ARK Investment Management LLCADD4,905,613$61.0M
UBS Group AGDOUBLED3,119,254$38.8M
MARSHALL WACE, LLPTRIM1,279,180$15.9M
MORGAN STANLEYADD1,128,667$14.0M
RENAISSANCE TECHNOLOGIES LLCTRIM632,989$7.9M
ALPS ADVISORS INCADD183,458$2.3M
MANUFACTURERS LIFE INSURANCE COMPANY, THEDOUBLED135,558$1.7M
GEODE CAPITAL MANAGEMENT, LLCADD109,590$1.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

25 analysts
Buy 92% rate it Buy or better
Strong Buy8Buy15Hold2Sell0Strong Sell0
12-month targets · 16 analysts

Price is below the lowest target. Median implies +154%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 9, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Nov 4, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Nov 3, 2026BTIG
REITERATE
REITERATEBuy
Aug 7, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Aug 6, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Aug 6, 2026RBC Capital
MAINTAIN
MAINTAINOutperform

Washington

Corporate Lobbying

22 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Aug 3, 2026
Nath Kabir
Chief Executive Officer
Aug 3, 2026
TAX W/H$67.1K
May 27, 2026
Norton David Y
Director
May 27, 2026
AWARD21,110 sh
May 27, 2026
Tregoning Kathleen
Director
May 27, 2026
AWARD41,119 sh
May 27, 2026
Riley Wayne Joseph
Director
May 27, 2026
AWARD21,110 sh
May 27, 2026
McQuade Robert
Director
May 27, 2026
AWARD21,110 sh
May 27, 2026
JONAS JEFFREY M
Director
May 27, 2026
AWARD21,110 sh
May 27, 2026
Gover Justin D.
Director
May 27, 2026
AWARD21,110 sh
May 27, 2026
SANTINI GINO
Director
May 27, 2026
AWARD30,158 sh

Earnings setup

Estimates
−$0.47
EPS estimate, this quarter
−18%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.47-$0.51–-$0.42-20.0%$0.00
Next Q-$0.38-$0.38–-$0.38+2.6%$71.4K
Current FY-$1.62-$1.86–-$1.38-7.6%$0.00
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
17,201,909
shares short
-2.6%
vs prior settlement
7.7
days to cover
≈12.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 3, 2026 SEC
Compass Pathways reported Q3 2026 results with a GAAP net loss of $9.8M ($0.07 basic / $0.31 diluted per share)…
8-K · Impact 6/10
Nov 3, 2026 Earnings result
CMPS Q3 2026 Earnings: EPS $-0.31 (+32.0% vs est)
Oct 28, 2026 SEC
BIT Capital GmbH, a German investment firm, filed a new Schedule 13G disclosing a 5.9% passive stake in COMPASS…
SC 13G · Impact 4/10
Sep 30, 2026 Inst.
ARK Investment Management LLC · ADD
4,905,613 shares ($61.0M)
Sep 30, 2026 Inst.
UBS Group AG · DOUBLED
3,119,254 shares ($38.8M)
Aug 10, 2026 SEC
Former director Annalisa Jenkins filed a Form 144 notice of intent to sell 26,000 American Depositary Shares of…
144 · Impact 3/10
Aug 3, 2026 Insider
Nath Kabir surrendered for taxes 5,962 shares
Chief Executive Officer @ $11.25 ($67.1K)
May 27, 2026 Insider
Norton David Y was granted 21,110 shares
Director
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 3 2 in posts · 1 in comments
Recent posts
All social signals and their track records

SecBot reports

6 filings · 2 bullish · 0 bearish · 4 neutral
All CMPS filing & press-release reports (6)